期刊文献+

早期扩张型心肌病心室重构内皮素转换酶的活性及其mRNA表达水平变化 被引量:1

Change of endothelin-converting enzyme in the early ventricular remodeling of dilated cardiomyopathy
下载PDF
导出
摘要 目的:探讨内皮素转换酶(ECE)在早期扩张型心肌病(DCM)心室重构中的变化,进一步研究DCM心室重构的发病机制。方法:两肾一夹术制备早期DCM大鼠模型后,通过RT-PCR-半定量法观察ECE mRNA表达水平的变化,并测定ECE活性以了解其蛋白质水平的变化。结果:早期DCM大鼠模型左室ECE mRNA表达水平为:1.25±0.37,ECE活性水平为:(58.3±9.1)pmol/L,二者均较正常对照组明显升高(P<0.05)。结论:早期DCM大鼠模型左室心肌ECE活性及mRNA表达水平与正常对照组相比显著上调,提示ECE可能参与了心室重构的形成。 Objective: To investigate the change of ECE in the early stage of dilated cardiomyopathy (DCM) and further to study the mechanism of ventricular remodeling. Methods: DCM rats models was developed by preparation of hypertension and diabetes rats. To observe the change of ECE mRNA expression by the method of RT-PCR and the protein level of ECE in left ventricle (LV) by measuring ECE activity . Results: ECE mRNA level of LV in DCM rats was higher than that in normal control groups( 1. 25 ± 0. 37 vs. 0. 69 ± 0. 32,P<0. 05). In addition, ECE activity of LV in DCM rats was increased significantly compared with that of normal control groups , (58.319.1 )pmol/L vs. (42. 4 ± 10. 5)pmol/L,P<0. 05. Conclusions: The mRNA expression and activity of ECE in the early DCM was obviously upregulated as compared with those in normal SD rats. This result suggests that ECE may be involved in the formation of ventricular remodeling.
出处 《国外医学(心血管疾病分册)》 2003年第5期315-317,共3页
关键词 扩张型心肌病 内皮素转换酶 心室重构 发病机制 Endothelin-converting Enzyme Ventricular remodeling Dilated cardiomyopathy
  • 相关文献

参考文献9

  • 1Hiroe M, Hiram Y, Fujita N, et al. Plasma endothelin-1 levels in idopathic dilated cardiomyopathy. Am J Cardiol, 1991, 68(10): 1114-1115.
  • 2Shimada K, Matsushita Y, Wakabayashi K, et al. Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun, 1995 , 207(2) :807-812.
  • 3Sawa A, Khan AA, Hester LD, et al. Glyceraldehyde-3-phosphate dehydrogenase:nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA,1997,94(21) : 11669-11674.
  • 4Engelhardt S, Bohm M, Erdmann E, et al. Analysis of Beta-adrenergic receptor mRNA levels in human vertricular biopsy specimens by quantitative polymerase chain reactions : progressive reduction of beta-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol ,1996,27(1):146-154.
  • 5Minamino T, Kurihara H, Takahasi M, et al. Endothelin-converting enzyme expression in the rat vascular iniury model and human coronary atherosclerosis. Circulation, 1997, 95 ( 1 ):221-230.
  • 6Zolk O, Quattek J, Sitzler G, et al. Expression of endothelin-1 ,endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation,1999,99(16) :2118-2123.
  • 7Ksander GM, Savage P, Trapani AJ, et al. Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24 11, and angiotension-converting enzyme. J Cardiovasc Pharmacol, 1998,31(Suppl 1):S71-S73.
  • 8Kaburagl S, Hasegawa K, Morimoto T, et al. The role of ECE-1 in the development of alphal-adrenergic-stimulated hypertrophy in cultured neonatal rat cardiac myocytes. Circulation, 1999,99(2) :292-298.
  • 9Ergul A, Grubbs AL, Zhang Y, et al. Selective upregulation of endothelin converting enzyme-la in the human failing heart.J Card Fail, 2000,6(4) :314-320.

同被引文献9

  • 1LIU,Yalan(刘雅兰),YAO,Bin(姚斌),ZHANG,Zigang(张子刚).ISO9000 and the Quality Management System in the Digital Hospital[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2002,22(2):89-91. 被引量:1
  • 2袁伟永,计剑,付金红,沈家骢.层层静电自组装构建壳聚糖/肝素抗菌多层膜的研究[J].高等学校化学学报,2005,26(10):1963-1965. 被引量:13
  • 3谭庆刚,林全愧,范德增,计剑,沈家骢.去质子化调控的肝素/壳聚糖抗凝血多层膜[J].高等学校化学学报,2006,27(4):787-789. 被引量:9
  • 4W. G. Liu,J. R. Zhang,Z. Q. Cao,F. Y. Xu,K. D. Yao. A chitosan-arginine conjugate as a novel anticoagulation biomaterial[J] 2004,Journal of Materials Science: Materials in Medicine(11):1199~1203
  • 5Ai-ping Zhu,Hao Wu,Jian Shen. Preparation and characterization of a novel Si-containing crosslinkable O-butyrylchitosan[J] 2004,Colloid and Polymer Science(11):1222~1227
  • 6F. Poncin-Epaillard,G. Legeay. Surface engineering of biomaterials with plasma techniques[J] 2003,Journal of Biomaterials Science, Polymer Edition(10):1005~1028
  • 7A. P. Zhu,Z. Zhang,J. Shen. Preparation and characterization of novel silica-butyrylchitosan hybrid biomaterials*[J] 2003,Journal of Materials Science: Materials in Medicine(1):27~31
  • 8M.-C. Yang,W.-C. Lin. Surface Modification and Blood Compatibility of Polyacrylonitrile Membrane with Immobilized Chitosan–Heparin Conjugate[J] 2002,Journal of Polymer Research(3):201~206
  • 9S. N. Chirkov. The Antiviral Activity of Chitosan (Review)[J] 2002,Applied Biochemistry and Microbiology(1):1~8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部